7.800USD0.00%Mkt Cap: 54.86M $P/E: —1d ago
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical syst…
Industry Peers
Drug Manufacturers - Generalvs Drug Manufacturers - General
1M Perf
Higher
$1.07TUSDP/E 42.6
$611.36BUSDP/E 29.4
$444.21BUSDP/E 123.9
$308.01BUSDP/E 21.1
$317.37BUSDP/E 36.2
$281.52BUSDP/E 22.5
$275.65BUSDP/E 22.4
$269.91BUSDP/E 28.1
$237.69BUSDP/E 28.0
$202.85BUSDP/E 11.5
$195.44BUSDP/E 25.2
$156.86BUSDP/E 17.2
$137.24BUSDP/E 18.4
$117.66BUSDP/E 16.1
$97.68BUSDP/E 19.0
$86.27BUSDP/E 14.0
$51.69BUSD
$31.90BUSDP/E 23.3
MRV
Marvell Technology, Inc.$30.93BUSDP/E 11.7
$11.35BUSDP/E 22.7
$11.02BUSDP/E 19.1
$10.98BUSDP/E 19.1
$6.60BUSDP/E 14.6
$3.56BUSDP/E 14.6
$3.03BUSDP/E 18.5
$39.77MUSD
ELXR
Elixxer Ltd.$9.51MUSD
CELG-RI
Bristol-Myers Squibb Company Ce—
PHOO
Photocure ASA—
FLXN
Horizon Flexible Income ETF—P/E 27.2
ROSE
DocMorris AG—
Indicators:|
Key Statistics
Company
Market Cap54.86M $
Enterprise Value153.00M $
Revenue (TTM)33.86M $
Gross Profit19.65M $
Net Income (TTM)-358.73M $
Revenue/Share3.432 USD
Last Price7.800 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees34
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)10.68
PEG—
EV/EBITDA-0.57
EV/Revenue4.52
P/S1.62
P/B-0.22
EPS (TTM)-40.50
EPS (Forward)0.73
52W Range
4.20012% of range34.27
52W High34.27 USD
52W Low4.200 USD
Profitability
Gross Margin64.97%
Oper. Margin-373.49%
EBITDA Margin0.00%
Profit Margin-1185.78%
ROE172.65%
ROA-98.29%
Growth
Revenue Growth72.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF3.82M $
CapEx (TTM)733.00K $
FCF Margin17.68%
FCF Yield10.91%
Net Debt103.00M $
Net Debt/EBITDA-0.38
Balance Sheet
Debt/Equity-0.60
Current Ratio0.08
Quick Ratio0.07
Book Value/Sh-35.4360 USD
Cash/Share0.4780 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1606:1000
Split DateJun 16, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.7.03M
Float5.19M
Insiders17.56%
Institutions13.11%
Short Interest
Short Ratio2.0d
Short % Float3.66%
Short % Out.2.89%
Shares Short203.08K
Short (prev mo.)157.97K
Technical
SMA 505.115 (+52.5%)
SMA 2007.775 (+0.3%)
Beta1.71
S&P 52W Chg20.05%
Avg Vol (30d)90.25K
Avg Vol (10d)97.49K
Technical Indicators
RSI (14)53.9
MACD0.0161
MACD Signal-0.0219
MACD Hist.+0.0380
BB Upper8.809 USD
BB Middle7.383 USD
BB Lower5.958 USD
BB Width38.61%
ATR (14)0.8655 USD
Vol Ratio (20d)0.69x